metoprolol has been researched along with Bright Disease in 5 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used a New Zealand white rabbit model of cationized bovine serum albumin (cBSA)-induced glomerulonephritis and then administered them metoprolol, irbesartan or acupuncture to evaluate the effectiveness of acupuncture treatment and preliminarily explore its potential mechanism." | 3.80 | "Qufeng Tongluo" acupuncture prevents the progression of glomerulonephritis by decreasing renal sympathetic nerve activity. ( An, P; Dang, HM; Shi, XM; Wu, XL; Ye, BY, 2014) |
| "One day after induction of anti-thy1 glomerulonephritis, rats were given increasing doses of the beta-blockers metoprolol or nebivolol (0." | 3.72 | Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis. ( Gaedeke, J; Ketteler, M; Liefeldt, L; Neumayer, HH; Peters, H; Rückert, M; Sharma, AM, 2003) |
| "Both treatments reduced proteinuria not only in hypertensive, but also in normotensive patients." | 2.67 | Angiotensin-converting enzyme inhibition and the combination of a beta blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis. ( Huysmans, FT; Kloke, HJ; Koene, RA; van Hamersvelt, HW; Wetzels, JF, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, P | 1 |
| Dang, HM | 1 |
| Shi, XM | 1 |
| Ye, BY | 1 |
| Wu, XL | 1 |
| Liesemer, K | 1 |
| Mullen, N | 1 |
| Peters, H | 1 |
| Rückert, M | 1 |
| Gaedeke, J | 1 |
| Liefeldt, L | 1 |
| Ketteler, M | 1 |
| Sharma, AM | 1 |
| Neumayer, HH | 1 |
| Daskas, N | 1 |
| Farmer, K | 1 |
| Coward, R | 1 |
| Erlewyn-Lajeunesse, M | 1 |
| Kloke, HJ | 1 |
| Wetzels, JF | 1 |
| van Hamersvelt, HW | 1 |
| Koene, RA | 1 |
| Huysmans, FT | 1 |
1 trial available for metoprolol and Bright Disease
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibition and the combination of a beta blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chlorthalidone; Drug Combinations; Fe | 1993 |
4 other studies available for metoprolol and Bright Disease
| Article | Year |
|---|---|
"Qufeng Tongluo" acupuncture prevents the progression of glomerulonephritis by decreasing renal sympathetic nerve activity.
Topics: Acupuncture Therapy; Animals; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Glome | 2014 |
Hypertensive emergency successfully treated with metoprolol: a case report.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cerebral Palsy; Child; Developmental Disabilities; Emerg | 2009 |
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzopyrans; Biomark | 2003 |
Meningococcal disease associated with an acute post-streptococcal complement deficiency.
Topics: Child; Complement System Proteins; Glomerulonephritis; Hematuria; Humans; Kidney; Leukocyte Count; M | 2007 |